Unknown

Dataset Information

Modification of globin gene expression by RNA targeting strategies.


ABSTRACT:

Objective

Sickle cell anemia is a genetic blood disease resulting from production of mutant beta-globin (beta(S)) and has severe clinical consequences. It is known that a higher cellular gamma-globin level, e.g., higher ratio of cellular gamma-globin to beta(S)-globin (gamma/beta(S) ratio), inhibits sickle hemoglobin (HbS) polymerization tendency. Hence, therapeutic treatment of sickle cell anemia has been focused on introducing gamma-globin gene into red blood cells to increase the cellular gamma/beta(S) ratio. Here, we have introduced ribozymes and small interfering RNAs (siRNAs) against beta(S)-globin mRNA into blood cells as a means to increase the gamma/beta(S) ratio.

Materials and methods

Single and multiribozymes against beta(S)-globin mRNA have been tested in vitro a

SUBMITTER: Shen TJ 

PROVIDER: S-EPMC2225584 | biostudies-literature | 2007 Aug

REPOSITORIES: biostudies-literature